Dow Up 0.51% Nasdaq Up 0.24%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
7.86 Up 0.01(0.13%) Nov 21, 4:00PM EST
|After Hours : 7.85 Down 0.01 (0.13%) Nov 21, 5:08PM EST
Prev Close:7.85
Open:7.94
Bid:N/A
Ask:9.70 x 2500
1y Target Est:8.00
Beta:0.61
Next Earnings Date:N/A
Day's Range:7.83 - 7.96
52wk Range:7.22 - 10.26
Volume:1,460,273
Avg Vol (3m):3,154,360
Market Cap:1.26B
P/E (ttm):3.99
EPS (ttm):1.97
Div & Yield:0.60 (7.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 0.13%1.26B
AMGNUp 0.08%123.84B
SGENUp 0.68%4.57B
XOMAUp 1.10%492.94M

Key Statistics

Forward P/E (1 yr):3.62
P/S (ttm):2.71
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.15
Quarterly EPS Est (Dec-14) :0.57
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.26

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback